Modelling the Human Placental Interface in Vitro—A Review

Total Page:16

File Type:pdf, Size:1020Kb

Modelling the Human Placental Interface in Vitro—A Review micromachines Review Modelling the Human Placental Interface In Vitro—A Review Marta Cherubini, Scott Erickson and Kristina Haase * European Molecular Biology Laboratory (EMBL), 08003 Barcelona, Spain; [email protected] (M.C.); [email protected] (S.E.) * Correspondence: [email protected]; Tel.: +34-936-282-716 Abstract: Acting as the primary link between mother and fetus, the placenta is involved in regulating nutrient, oxygen, and waste exchange; thus, healthy placental development is crucial for a successful pregnancy. In line with the increasing demands of the fetus, the placenta evolves throughout pregnancy, making it a particularly difficult organ to study. Research into placental development and dysfunction poses a unique scientific challenge due to ethical constraints and the differences in morphology and function that exist between species. Recently, there have been increased efforts towards generating in vitro models of the human placenta. Advancements in the differentiation of human induced pluripotent stem cells (hiPSCs), microfluidics, and bioprinting have each contributed to the development of new models, which can be designed to closely match physiological in vivo conditions. By including relevant placental cell types and control over the microenvironment, these new in vitro models promise to reveal clues to the pathogenesis of placental dysfunction and facilitate drug testing across the maternal-fetal interface. In this minireview, we aim to highlight current in vitro placental models and their applications in the study of disease and discuss future avenues for these in vitro models. Keywords: placenta; maternal-fetal interface; trophoblast invasion; bioprinting; microfluidics; placenta-on-a-chip; in vitro models Citation: Cherubini, M.; Erickson, S.; Haase, K. Modelling the Human Placental Interface In Vitro—A Review. Micromachines 2021, 12, 884. 1. Introduction https://doi.org/10.3390/mi12080884 The human placenta is a crucial organ that supports fetal development throughout gestation. Placental growth and function are precisely regulated to ensure effective circula- Academic Editor: Aleksander Skardal tion of oxygen and nutrients, removal of waste, generation and release of metabolites, and protection against diseases, infections, and xenobiotic transfer to the fetus [1]. Considering Received: 27 June 2021 its vital role, it is essential to understand placental development and the causes of its Accepted: 24 July 2021 dysfunction. However, due to ethical concerns, our understanding of the placenta is largely Published: 27 July 2021 derived from explants at term or from unsuccessful pregnancies. Explants have provided many clues into pathological pregnancies, such as fetal growth restriction, pre-eclampsia, Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in and stillbirth at varied stages of disease [2–4]. However, explants begin to degenerate published maps and institutional affil- within hours after collection, making experimentation with human tissue challenging. iations. Efforts have been made to develop accurate animal models [5]; however, considerable differences between species make it difficult to develop a non-primate animal model that fully mimics human placentation [6,7]. Rodent models are useful for understanding spe- cific aspects of placentation, but many processes are difficult to assess in vivo. Ultimately, bioengineered in vitro models promise to bridge the gap between species and offer precise Copyright: © 2021 by the authors. control over the microenvironment to recapitulate specific aspects of human placentation Licensee MDPI, Basel, Switzerland. This article is an open access article in health and disease [8]. distributed under the terms and This minireview aims to: (1) discuss our current understanding of human placentation conditions of the Creative Commons and highlight areas that require further investigation; (2) discuss current in vitro placental Attribution (CC BY) license (https:// systems, ranging from 2D to 3D models; (3) explore recent applications of these models in creativecommons.org/licenses/by/ studying placental physiology and disorders; and (4) discuss key components to consider 4.0/). when developing or evaluating an in vitro model of the placenta. Micromachines 2021, 12, 884. https://doi.org/10.3390/mi12080884 https://www.mdpi.com/journal/micromachines Micromachines 2021, 12, x FOR PEER REVIEW 2 of 14 Micromachines 2021, 12, 884 2 of 14 models in studying placental physiology and disorders; and (4) discuss key components to consider when developing or evaluating an in vitro model of the placenta. 2. Development Development and and Functions of the Human Placenta The placenta, a fetal organ, forms shortly after fertilization and continues to change throughoutthroughout pregnancy pregnancy in in response to the metabolicmetabolic demandsdemands ofof thethe fetus.fetus. PlacentationPlacentation begins post-fertilization post-fertilization when when the the blastocyst blastocyst attaches attaches to to the the inner inner layer layer (endometrium) (endometrium) of theofthe uterus. uterus. The Theblastocyst blastocyst then begins then begins to inva tode invade the endometrium the endometrium with the with helpthe of its help outer of layerits outer of cells, layer termed of cells, trophoblasts. termed trophoblasts. This fetal trophoblastic This fetal trophoblastic layer is divided layer into is two divided cell types,into two an cellexternal types, multinucleated an external multinucleated syncytiotrophoblast syncytiotrophoblast layer (the invasive layer trophoblasts) (the invasive andtrophoblasts) an inner cytotrophoblast and an inner cytotrophoblast layer. About two layer. weeks About after two fertilization, weeks after the fertilization, external syn- the cytiotrophoblastexternal syncytiotrophoblast forms preliminary forms preliminary fluid-filled fluid-filledvilli structures villi structuresdirected outward, directed outward,towards thetowards decidual the deciduallayer of the layer mother’s of the mother’suterus (Fig uterusure 1a). (Figure Then,1a). the Then, cytotrophoblasts the cytotrophoblasts prolifer- ateproliferate and migrate and migrate through through the syncytiotrophoblasti the syncytiotrophoblasticc layer to layer form to the form primary the primary villi [9]. villi Soon, [9]. theseSoon, thesevilli expand villi expand and andbecome become vascularized vascularized with with fetal fetal placental placental vessels. vessels. Meanwhile, Meanwhile, trophoblaststrophoblasts remodel remodel the the maternal maternal spiral spiral arte arteriesries of of the decidua, which become dilated, allowing for for maternal maternal blood blood to tofill fillthe the intervillous intervillous space. space. As a result, As a result, there is there a large is surface a large areasurface for areathe exchange for the exchange of nutrients of nutrients traveling traveling from the from mother’s the mother’s circulation circulation into the intervil- into the intervillous spaces, through the trophoblast layers, and into the closed placental circulation lous spaces, through the trophoblast layers, and into the closed placental circulation of the of the villi, which nourishes the fetus via the umbilical cord [10,11]. By the second trimester, villi, which nourishes the fetus via the umbilical cord [10,11]. By the second trimester, the the main features of the mature placenta are formed (Figure1b). main features of the mature placenta are formed (Figure 1b). Figure 1. PlacentalPlacental development development timeline, trophoblast in invasion,vasion, and mature placental structure. ( a) Diagram Diagram of trophoblast trophoblast invasion around around day day 9, 9, wherein wherein the the syncytiotrophoblast syncytiotrophoblast laye layerr surrounding surrounding the embryoblast the embryoblast begins begins to invade to invade the endome- the en- trium. (b) Mature placental structure showing maternal and fetal vasculature. (c) Focus on exchange of nutrients between dometrium. (b) Mature placental structure showing maternal and fetal vasculature. (c) Focus on exchange of nutrients open maternal blood and closed fetal circulation across the two trophoblastic layers. between open maternal blood and closed fetal circulation across the two trophoblastic layers. Nutrient exchange exchange between between maternal maternal and and feta fetall blood blood is facilitated is facilitated largely largely by the by syn- the cytiotrophoblast,syncytiotrophoblast, which which is one is one continuous continuous multinucleated multinucleated layer layer of of cells cells (Figure (Figure 11c).c). TheThe ability of nutrients to cross this layer depends on transporter proteins and its thickness, which isis reducedreduced nearnear the the vascularized vascularized parts parts of of the the villi villi [12 ].[12]. Small Small hydrophobic hydrophobic molecules, mole- cules,such as such oxygen as oxygen and carbon and carbon dioxide, dioxide, can easily can diffuse easily acrossdiffuse plasma across membranes plasma membranes in response in responseto differences to differences in the concentration in the concentration gradient between gradient maternal between and maternal fetal blood, and which fetal blood, varies whichwith the varies maternal with the blood maternal supply, blood environment, supply, environment, and rate of blood and rate flow. of Partialblood flow. pressure Partial of oxygen in the maternal blood is considerably higher than in the fetal blood,
Recommended publications
  • CCM2 and CCM3 Proteins Contribute to Vasculogenesis and Angiogenesis in Human Placenta
    Histol Histopathol (2009) 24: 1287-1294 Histology and http://www.hh.um.es Histopathology Cellular and Molecular Biology CCM2 and CCM3 proteins contribute to vasculogenesis and angiogenesis in human placenta Gamze Tanriover1, Yasemin Seval1, Leyla Sati1, Murat Gunel2 and Necdet Demir1 1Department of Histology and Embryology, Akdeniz University, School of Medicine, Antalya, Turkey and 2 Department of Neurosurgery, Yale University, School of Medicine, New Haven, CT, USA Summary. Placenta as an ideal model to study Introduction angiogenic mechanisms have been established in previous studies. There are two processes, The placenta is a multifaceted organ that plays a vasculogenesis and angiogenesis, involved in blood critical role in maintaining and protecting the developing vessel formation during placental development. fetus. Normal development and function of the placenta Therefore, blood vessel formation is a crucial issue that requires extensive vasculogenesis and subsequent might cause vascular malformations. One of the vascular angiogenesis, in both maternal and fetal tissues. malformations is cerebral cavernous malformation Vasculogenesis is the formation of the primitive vascular (CCM) in the central nervous system, consisting of network de novo from progenitor cells, and angiogenesis endothelium-lined vascular channels without intervening is identified as the extension of blood vessels from normal brain parenchyma. Three CCM loci have been preexisting vascular structures (Demir et al., 1989, 2006; mapped as Ccm1, Ccm2, Ccm3 genes in CCM. In order Geva et al., 2002; Charnock-Jones et al., 2004). Many to investigate whether CCM proteins participate in blood factors, such as vascular endothelial growth factor vessel formation, we report here the expression patterns (VEGF), angiopoietins (Angpt-1 and -2) and their of CCM2 and CCM3 in developing and term human receptors are involved in the molecular regulation of placenta by means of immunohistochemistry and these diverse developmental steps.
    [Show full text]
  • The Placenta
    The placenta Learning module Developed by Carolyn Hammer Edited by Fabien Giroux Diagrams By Dr Julien Yockell Lelievre where indicated The placenta – Learning module Table of content 1) Introduction……………………………………………………………………….3 2) Anatomy and Physiology………………………………………………………..6 3) Roles and Functions……………………………………………………………17 4) Development and formation…………………………………..…………….…27 5) What happens after birth……………………………………………….……...34 6) What happens when things go wrong.……………………………………….36 7) Interesting facts about pregnancy………………….…………………………46 2 The placenta – Learning module Introduction 3 The placenta – Learning module What is the placenta? •The placenta is a “vascular (supplied with blood vessels) organ in most mammals that unites the fetus to the uterus of the mother. It mediates the metabolic exchanges of the developing individual through an intimate association of embryonic tissues and of certain uterine tissues, serving the functions of nutrition, respiration, and excretion.” (Online Britannica encyclopaedia) •As the fetus is in full development, it requires a certain amount of gases and nutrients to help support its growth. Because the fetus is unable to do so on its own, the placenta provides these gases and nutrients throughout pregnancy. http://health.allrefer.com/health/plac enta-abruptio-placenta.html 4 The placenta – Learning module What are the main roles of the placenta? •The placenta provides the connection between fetus and mother in order to help carry out many different functions that the growing baby is incapable to do so alone. During pregnancy, the placenta has 6 main roles to maintain good health and a good environment for the growing child: •Respiration •Nutrition •Excretion •Protection •Endocrine •Immunity 5 The placenta – Learning module Anatomy and physiology 6 The placenta – Learning module Structure •A placenta is an organ of round or oval shape that is relatively flat.
    [Show full text]
  • The Structural Heterogeneity of Chorial Villi Phenotype Determined by Angiogenesis
    Rom J Leg Med [19] 197-210 [2011] DOI: 10.4323/rjlm.2011.197 © 2011 Romanian Society of Legal Medicine The structural heterogeneity of chorial villi phenotype determined by angiogenesis. Implications in legal pathology Gheorghe S. Dragoi*, Petru Razvan Melinte, Daniel Zimta, Mohab El Din Mohamed _________________________________________________________________________________________ Abstract: Micro anatomic phenotype of chorial villi can be achieved only by means of a rigurous evaluation of its structural elements: trophoblast, vascular and mesenchyme. The authors proposed themselves to study the reciprocal relations between syncytiotrophoblast, fetal sinusoid capillaries and argentic collagen fiber fascicles inside chorial villi depending on angionesis process. The research was carried out on human biologic material using placenta fragments during 28-37 weeks of gestation. The authors consider that the collagen IV stereo distribution inside the vascular pedicle of the terminal villi, contributes to the stability, biodynamic and biokinematics of villi phenotype that is determined by branching or non branching angiogenesis. The personal results have a great value for stating the variability limits of terminal villi phenotype in ortology as well as in general or forensic pathology. Key Words: terminal villi, angiogenesis, collagen IV, villi phenotype he chorial villi phenotype is determined either by vasculogenesis either by angiogenesis. It Tis considered that until the end of gestation, the blood capillaries network reaches 550 km in length and 15 m2 in surface (Burton and Jauniaux, 1995) [7]. Angiogenesis plays an important role in formation and remodeling of blood vessels inside human placenta terminal villi. In the second half of gestation there is a growth acceleration and an increase in number for mature intermediate and terminal villi and for sinusoid blood capillaries (Mayhew, 2002) [22].
    [Show full text]
  • Placental Findings and Effect of Prophylactic Hydrocortisone in Extremely Preterm Infants
    Placental Findings and Effect of Alice Héneau, MD, a Fabien Guimiot, PD, PhD, b Damir Mohamed, MSc, c, d Aline Rideau Batista Novais, MD, PhD, a ProphylacticCorinne Alberti, MD, PhD, c, d Olivier Baud, HydrocortisoneMD, PhD, a, e for the PREMILOC Trial study group in Extremely Preterm Infants OBJECTIVES: abstract To investigate the relationship between histologic findings of the placenta and response to early postnatal hydrocortisone treatment used to prevent bronchopulmonary METHODS: dysplasia (BPD) in extremely preterm infants. In an exploratory analysis of the Early Low-Dose Hydrocortisone to Improve Survival Without Bronchopulmonary Dysplasia in Extremely Preterm Infants (PREMILOC) trial, detailed placental analyses were performed on the basis of standardized macroscopic and histologic examinations. Placental histology, categorized into 3 groups, was correlated RESULTS: to neonatal outcomes and response to hydrocortisone treatment. Of 523 randomly assigned patients, 457 placentas were analyzed. In total, 125 out of 457 (27%) placentas were classified as normal, 236 out of 457 (52%) placentas were classified as inflammatory, and 96 out of 457 (21%) placentas were classified as vascular. ’ Placental inflammation was associated with a significant, increased rate of BPD-freeP survival at 36 weeks postmenstrual age, independent of gestational age, treatment group, and sex (adjusted odds ratio: 1.72, 95% confidence interval [CI]: 1.05 to 2.82, = .03). Regarding the response to treatment, the strongest benefit of hydrocortisone Pcompared with placebo was found in infants born after placental vascular disease, with significantly more Ppatients extubated at day 10 (risk difference: 0.32, 95% CI: 0.08 to 0.56, = .004) and similar positive direction on survival without BPD (risk difference: 0.23, 95% CI: 0.00 to 0.46, = .06).
    [Show full text]
  • Twin Transfusion Syndrome
    Obstetrica }i Ginecologia LXVI (2018) 129-133 Review article UNDERSTANDING THE PATHOPHYSIOLOGY OF THE TWIN-TO- TWIN TRANSFUSION SYNDROME N. Suciu1,2, A.Oncescu1, Andreea-Cătălina Fetecău1, L. Pop1, Oana Toader1,2 1Departament of Obstetrics and Gynecology, “Alessandrescu-Rusescu” National Institute for Mother and Child Care, Polizu Hospital, Bucharest. 2 Department of Obstetrics and Gynecology, ”Carol Davila” University of Medicine and Pharmacy, Bucharest Abstract Twin-to-twin transfusion syndrome (TTTS) also known as twin oligohydramnios-polyhydramnios sequence (TOPS) is considered to be one of the most frequent complications of monochorionic diamniotic pregnancies. The placenta lies at the core of the TTTS pathophysiology and during the past two decades, numerous studies have been carried out in order to help understand the transfusional mechanisms. The placental anastomoses, which are the primary mediators of transfusional imbalance are incapable of fully explaining the disease and also the negative impact it has on both the renal and cardiovascular systems. The current paper is aimed at providing an insight into the placental and fetal pathophysiology of the syndrome after reviewing the current articles published in the literature. Rezumat Sindromul transfuzor-transfuzat (TTTS), cunoscut si sub denumirea de secventa oligohidramnios- polihidramnios (TOPS) este considerat a fi una dintre cele mai frevvente si severe complicatii ce apar la sarcinile gemelare monocoriale, biamniotice. Placentatia jocă un rol substantial în fiziopatologia sindromului transfuzor- transfuzat si, în ultimii 20 de ani, numaroase studii au fost efectuate pentru a ajuta la întelegerea mecanismelor transfuzionale ce stau la baza acestui tip de sindrom. Anastomozele placentare, depistate la sarcinile gemelare cu TTTS si principalii mediatori răspunzători de dezechilibrul transfuzional sunt insuficienti pentru a putea explica aparitia sindromului precum si impactul negativ al acestuia asupra sistemelor renal si cardiovascular fetale.
    [Show full text]
  • Evaluation of Prenatal Adenoviral Vascular Endothelial Growth Factor Gene Therapy in the Growth-Restricted Sheep Fetus and Neonate
    Evaluation of Prenatal Adenoviral Vascular Endothelial Growth Factor Gene Therapy in the Growth-Restricted Sheep Fetus and Neonate David John Carr University College London 2013 A thesis submitted for the degree of Doctor of Philosophy 1 Declaration I, David Carr, confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis. 2 Abstract Background Fetal growth restriction (FGR) is associated with reduced uterine blood flow (UBF). In normal sheep pregnancies, adenovirus (Ad) mediated over-expression of vascular endothelial growth factor (VEGF) in the uterine arteries (UtA) increases UBF. It was hypothesised that enhancing UBF would improve fetal substrate delivery in an ovine paradigm of FGR characterised by reduced UBF from mid-gestation. Methods Singleton pregnancies were established using embryo transfer in adolescent ewes subsequently overnourished to generate FGR (n=81). Ewes were randomised mid-gestation to 11 receive bilateral UtA injections of 5x10 particles Ad.VEGF-A165 or inactive treatment (saline or 5x1011 particles Ad.LacZ, a control vector). Fetal growth/wellbeing were evaluated using serial ultrasound. Late-gestation study: UBF was monitored using indwelling flowprobes until necropsy at 0.9 gestation. Vasorelaxation, neovascularisation in perivascular adventitia and placental mRNA expression of angiogenic factors/receptors were examined. A group of control-fed ewes with normally-developing fetuses was included (n=12). Postnatal study: Pregnancies continued until spontaneous delivery near to term. Lambs were weighed and measured weekly and underwent metabolic challenge at 7 weeks, dual-energy X-ray absorptiometry at 11 weeks, and necropsy at 12 weeks postnatal age.
    [Show full text]
  • 6 Development of the Great Vessels and Conduction Tissue
    Development of the Great Vessels and Conduc6on Tissue Development of the heart fields • h:p://php.med.unsw.edu.au/embryology/ index.php?6tle=Advanced_-_Heart_Fields ! 2 Septa6on of the Bulbus Cordis Bulbus Cordis AV Canal Ventricle Looking at a sagital sec6on of the heart early in development the bulbus cordis is con6nuous with the ventricle which is con6nuous with the atria. As the AV canal shiOs to the right the bulbus move to the right as well. Septa6on of the Bulbus Cordis A P A P The next three slides make the point via cross sec6ons that the aorta and pulmonary arteries rotate around each other. This means the septum between them changes posi6on from superior to inferior as well. Septa6on of the Bulbus Cordis P A A P Septa6on of the Bulbus Cordis P A P A Migra6on of neural crest cells Neural crest cells migrate from the 3ed, 4th and 6th pharyngeal arches to form some of the popula6on of cells forming the aor6copulmonary septum. Septa6on of the Bulbus Cordis Truncal (Conal) Swellings Bulbus Cordis The cardiac jelly in the region of the truncus and conus adds the neural crest cells and expands as truncal swellings. Septa6on of the Bulbus Cordis Aorticopulmonary septum These swellings grow toward each other to meet and form the septum between the aorta and pulmonary artery. Aorta Pulmonary Artery Septa6on of the Bulbus Cordis Anterior 1 2 3 1 2 3 The aor6copulmonary septum then rotates as it moves inferiorly. However, the exact mechanism for that rota6on remains unclear. Septa6on of the Bulbus Cordis Aorta Pulmonary Artery Conal Ridges IV Foramen Membranous Muscular IV Endocarial Septum Interventricular Cushion Septum However, the aor6copulmonary septum must form properly for the IV septum to be completed.
    [Show full text]
  • Preface Preface from the Editors
    Preface Preface from the Editors t is with both excitement and sadness that we present to etry came onto the stage, dramatically changing the newborn you the final issue of the UTMJ for the 2011-2012 aca- screen to include the identification of more than 50 metabol- Idemic year. Serving as your Editors-in-Chief this year has ic disorders.3 However, with the increasing ability to identify been an immense pleasure, and has allowed us the oppor- disorders comes the complex challenge of treating them, and tunity to carry on the many exciting endeavours and initia- the ensuing debate on the value of identifying a disorder if no tives associated with the UTMJ. For our final issue, we decided viable or definitive treatment currently exists.3 to focus on a topic that is widely popular, multifaceted and The topic of fetal treatment is another issue that often sometimes controversial: obstetrics and gynaecology. comes into the news headlines, with astonishing advances in The landscape of obstetrics and gynaecology is an ever- fetal therapy and fetal surgery. Familiar early fetal therapies changing one. For example, something as seemingly simple include simple procedures, such as the first transplacental as contraception has seen a continuous stream of changes and administration of glucorticoids to mature fetal lungs in situ- advancements over the years, which is evident in our Histori- ations of premature delivery in 1972.4 More advanced fetal cal Perspective article published by Foster in 1969. The prac- surgeries began in the 1980s, often credited
    [Show full text]
  • New Perspectives on the Late-Term Mare and Newborn Foal
    IN-DEPTH: PERINATOLOGY—END OF PREGNANCY THROUGH BEGINNING OF LIFE New Perspectives on the Late-Term Mare and Newborn Foal Wendy Vaala, VMD, Diplomate ACVIM Author’s address: Equine Technical Services, Intervet Inc., 29160 Intervet Lane, Millsboro, DE 19966; e-mail: [email protected]. © 2007 AAEP. 1. Introduction dotal observations and conclusions can be inferred, A successful perinatal program requires the col- because there is not a large enough number of clin- laborative efforts of those trained in reproduction ical cases with similar problems from which to and neonatology. In ambulatory situations, one draw significant conclusions. Until larger, multi- person must often specialize in both areas; addition- centric collaborative trials validate the usefulness of ally, that person must have the equipment and monitoring specific hormones or the efficacy of var- expertise available to manage obstetrical complica- ious therapies designed to manage and maintain tions and to provide neonatal resuscitation and complicated pregnancies, it is the author’s recom- nursing care. Periparturient complications during mendation that no one therapy or monitoring aid late pregnancy may include severe maternal illness should be relied on exclusively. Any mare receiv- or colic, reproductive tract disease, or fetal anoma- ing therapy to prolong an abnormal pregnancy lies. The most serious threats to uteroplacental should receive frequent assessment. That way, the health and foal survival are perinatal sepsis, hypox- clinician can promptly determine if silent or unde- ia/ischemia, and maturation disorders. The chal- tected fetal demise occurs without ensuing abortion lenge is to improve our ability to recognize mares or if parturition occurs without the customary warn- with jeopardized pregnancies at an earlier stage in ing signs.
    [Show full text]
  • Equine Placenta – Marvelous Organ and a Lethal Weapon
    Equine placenta – marvelous organ and a lethal weapon Malgorzata Pozor, DVM, PhD, Diplomate ACT Introduction Placenta has been defined as: „an apposition between parent (usually maternal) and fetal tissue in order to establish physiological exchange” (1). Another definition of this important organ was proposed by Steven and Morris: „a device consisting of one or more transport epithelia located between fetal and maternal blood supply” (2). The main function of placenta is to provide an interface between the dam and the the fetus and to allow the metabolic exchange of the the nutrients, oxygen and waste material. The maternal circulation is brought into a close apposition to the fetal circulation, while a separation of these two circulatory systems remain separated (3). A degree and complexity of this „intimate relationship” varies greately between species mostly due to the structural diversity of the extraembryonic membranes of the vertebrates. The early feto-maternal exchange in the equine pregnancy is established as early as on day 22 after fertilization. The fetal and choriovitellin circulations are already present, the capsule ruptures and the allantois is already visible (4). The allantois starts expanding by day 32 and vascularizes approximately 90% of the chorion and fuses with it to form chorioallantois by day 38 of gestation (5). The equine placenta continues increasing its complexity till approximately day 150 of gestation. Equids have epitheliochorial placenta, there are six leyers separating maternal and fetal circulation, and there are no erosion of the luminal, maternal epithelium, like in ruminants (6). Thousands of small chorionic microvilli develop and penetrate into endometrial invaginations.
    [Show full text]
  • Taking Your Placenta Home
    Taking Your Placenta Home www.bcwomens.ca At BC Women’s, our goal is to make 3. It is strongly urged that you or sure your care is safe. If you choose anyone else do not eat your to take your placenta home, you and placenta in any form. your family should know about the 4. If the placenta is buried, it is risks and the right way to handle your recommended that it be buried no placenta. less than one meter deep and away from water sources to stop it from Health and Safety being eaten by animals and being a The placenta is a perfect place for source of infection to people. germs to grow. Germs can cause infection and make people sick. To 5. The placenta cannot be lower the risk of infection to you and thrown out in the normal other people these steps must be garbage. If you do not want taken: your placenta after taking it home you must bring it back to your doctor 1. Take the placenta home right or midwife. They will throw it out away and keep it in a cool place. properly. It should be stored in a fridge (3- 7°C) that does not hold any food. Regular Placenta Handling If you are planning on keeping the placenta for more than 2 days it • Once you birth the placenta your must be frozen. doctor or midwife will check it and put it in a plastic bag labeled with 2. While the risk of getting an infection your hospital ID sticker from a healthy placenta is low, standard cleaning habits must • If you would like to take your always be followed.
    [Show full text]
  • From Trophoblast to Human Placenta
    From Trophoblast to Human Placenta (from The Encyclopedia of Reproduction) Harvey J. Kliman, M.D., Ph.D. Yale University School of Medicine I. Introduction II. Formation of the placenta III. Structure and function of the placenta IV. Complications of pregnancy related to trophoblasts and the placenta Glossary amnion the inner layer of the external membranes in direct contact with the amnionic fluid. chorion the outer layer of the external membranes composed of trophoblasts and extracellular matrix in direct contact with the uterus. chorionic plate the connective tissue that separates the amnionic fluid from the maternal blood on the fetal surface of the placenta. chorionic villous the final ramification of the fetal circulation within the placenta. cytotrophoblast a mononuclear cell which is the precursor cell of all other trophoblasts. decidua the transformed endometrium of pregnancy intervillous space the space in between the chorionic villi where the maternal blood circulates within the placenta invasive trophoblast the population of trophoblasts that leave the placenta, infiltrates the endo– and myometrium and penetrates the maternal spiral arteries, transforming them into low capacitance blood channels. Sunday, October 29, 2006 Page 1 of 19 From Trophoblasts to Human Placenta Harvey Kliman junctional trophoblast the specialized trophoblast that keep the placenta and external membranes attached to the uterus. spiral arteries the maternal arteries that travel through the myo– and endometrium which deliver blood to the placenta. syncytiotrophoblast the multinucleated trophoblast that forms the outer layer of the chorionic villi responsible for nutrient exchange and hormone production. I. Introduction The precursor cells of the human placenta—the trophoblasts—first appear four days after fertilization as the outer layer of cells of the blastocyst.
    [Show full text]